glp 1 receptor agonists beyond their pancreatic effects GLP-1 as Treatments for Type 2 Diabetes GLP-1 and health: Beyond weight

Description

Human trials are underway to test their use in Parkinsons and cognitive decline

Its titration schedule is as follows: Week 1 (starting dose) : 0.6 mg per day Week 2: 1.2 mg per day Week 3: 1.8 mg per day Week 4: 2.4 mg per day Week 5 and onwards : 3 mg per day (therapeutic or maintenance dose) Rybelsus (semaglutide) daily oral dosing schedule Rybelsus comes in two formulations: R1 and R2

Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3) Diabetes Care

18 Gastric emptying modulation : Like GLP-1 receptor agonists, allulose delays gastric emptying, contributing to improved postprandial glucose control

So now theyre saying theres going to be a huge increase in the utilization of GLP-1s, not just for weight loss, but you may go to a physician that may diagnose you with this condition when really you want the GLP-1s for weight loss